
SBBC.V reported its fiscal year 2024 results with revenue reaching $45.3 million, marking a 69% increase from $26.8 million in 2023. Gross revenue rose 89% to $55.9 million, while TRUBAR™ revenue grew 77% to $43.6 million. Despite this growth, TRUBAR sales were below previous guidance, which had been reduced from a range of $45–50 million to $45 million, and ultimately reported at $43.6 million. Gross profit margin was also considered disappointing. The company did not provide guidance for the upcoming period and abandoned its previous merger and acquisition strategy. Market expectations had been high prior to the earnings release, but there is cautious optimism that if first quarter and full-year guidance next month are favorable, the stock could recover. Recent acceleration in direct-to-consumer sales and distribution wins had raised estimates to $48.8 million in sales for 2024 and $77.6 million for 2025, but these were not met in the current report.
$SBBC.v $SBBCF Mixed bag from Trubar. Sales were below estimates and no guidance, but they abandoned their unpopular M&A strategy. Expectations were way too high heading into this print, but if Q1/FY guide looks good next month I think we're back to highs. Adding a little here
$SBBC.V (last time I use this ticker?) FY results are out! Lots to unpack but nothing too surprising as results were well telegraphed by management in the last few weeks. If your appetite is whetted, keep scrolling. 1/x
$SBBC.V Trubar sales are disappointing, in my opinion. They previously reduced the guidance from 45–50 to 45, and now it's just 43.6. GPM is also disappointing. We'll have to wait for the call—maybe a larger order was once again shifted to the next quarter. The name change and https://t.co/7spsiBino1
